Phio Pharmaceuticals Corp (PHIO)

[Nothole]

Why a Reverse Split is unlikely this time:

The overwhelming driving force for any corporation's significant increase in valuation is PERSONAL GREED.

What is different this time = is that within the past 6 months the former CEO and the current CEO have each acquired about a HALF MILLION SHARES OF PHIO STOCK as well as Key Employees were given tens of thousands of shares. It is highly unlikely that the new CEO Dr. Gerrit Dispersyn would want to suffer any RS dilution going forward. If PHIO misses the May 13th deadline then it is most likely that PHIO will show evidence to the NASD of eminent business advancements and would be granted an Extension by the NASD as Phio Pharma has said can be done.